Pembrolizumab in patients with recurrent thymic carcinoma: Results of a phase II study.

被引：9
|
作者：
Giaccone, Giuseppe
Thompson, Jillian
McGuire, Colleen
Manning, Maria
Kallakury, Bhaskar
Chahine, Joeffrey J.
Subramaniam, Deepa Suresh
Liu, Stephen V.
Gibney, Geoffrey Thomas
Kim, Chul
McCutcheon, Justine N.
机构：
[1] Georgetown Univ, Washington, DC USA
[2] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
[3] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA
[4] Georgetown Univ Hosp, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA
[5] NIH, NCI, Thorac & Gastrointestinal Oncol Branch, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.8573
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8573
引用
收藏
页数：5
相关论文
共 50 条
  • [1] A phase II study of pembrolizumab in patients with recurrent thymic carcinoma.
    Giaccone, Giuseppe
    Thompson, Jillian
    Crawford, Jenny
    McGuire, Colleen
    Manning, Maria
    Subramaniam, Deepa Suresh
    Liu, Stephen V.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] A Phase II Study of Pemetrexed in Patients with Recurrent Thymoma and Thymic Carcinoma
    Gbolahan, Olumide B.
    Porter, Ryan F.
    Salter, John T.
    Yiannoutsos, Constantin
    Burns, Matthew
    Chiorean, E. Gabriella
    Loehrer, Patrick. J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : 1940 - 1948
  • [3] Anlotinib for patients with recurrent or metastatic nasopharyngeal carcinoma: A phase II study.
    Cai, Qingqing
    Su, Ning
    Fang, Yu
    Zou, Qihua
    Xia, Yi
    Ma, Shuyun
    Cai, Jun
    Liu, PanPan
    Wang, Jinni
    Zhang, Yuchen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18020 - E18020
  • [4] EFFICACY OF PEMBROLIZUMAB IN PATIENTS WITH PITUITARY CARCINOMA: RESULTS FROM A PHASE II STUDY
    Majd, Nazanin
    Waguespack, Steven
    Filip, Janku
    Fu, Siqing
    Penas-Prado, Marta
    Xu, Mingxuan
    Alshawa, Anas
    Kamiya-Matsuoka, Carlos
    Raza, Shaan
    McCutcheon, Ian
    Aung, Naing
    NEURO-ONCOLOGY, 2020, 22 : 39 - 40
  • [5] PHASE II AND BIOMARKER STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA PATIENTS
    Reardon, David
    Molinaro, Annette
    Peters, Katherine
    Clarke, Jennifer
    Jordan, Justin
    de Groot, John
    Nghiemphu, Phioanh
    Kaley, Thomas
    Colman, Howard
    McCluskey, Christine
    Smith, Timothy
    Cote, David
    Severgnini, Mariano
    Yearley, Jennifer
    Zhao, Qing
    Blumenschein, Wendy
    Duda, Gabriel
    Muzikansky, Alona
    Jain, Rakesh
    Wen, Patrick
    Nayak, Lakshmi
    NEURO-ONCOLOGY, 2020, 22 : 40 - 40
  • [6] A Phase II Study of Pembrolizumab for Patients with Refractory or Relapsed Thymic Epithelial Tumor
    Cho, J.
    Yoo, K. H.
    Lee, H.
    Kim, H. K.
    Kim, Y.
    Cho, J. H.
    Lim, S. W.
    Park, S. E.
    Sun, J.
    Lee, S.
    Ahn, J. S.
    Park, K.
    Ahn, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1749 - S1750
  • [7] Phase II study of pembrolizumab or pembrolizumab plus bevacizumab for recurrent glioblastoma (rGBM) patients
    Reardon, David A.
    Nayak, Lakshmi
    Peters, Katherine B.
    Clarke, Jennifer Leigh
    Jordan, Justin T.
    De Groot, John Frederick
    Nghiemphu, Phioanh Leia
    Kaley, Thomas Joseph
    Colman, Howard
    Gaffey, Sarah C.
    Caruso, Victoria
    Debruyne, Myriam Bednarek
    Bhavsar, Chinmay
    Molinaro, Annette M.
    Smith, Timothy
    Severgnini, Mariano
    Wen, Patrick Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] A phase II trial of pemetrexed in patients with recurrent thymoma or thymic carcinoma.
    Loehrer, P. J., Sr.
    Yiannoutsos, C. T.
    Dropcho, S.
    Burns, M.
    Helft, P.
    Chiorean, E. G.
    Nelson, R. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 383S - 383S
  • [9] Exemestane in advanced and recurrent endometrial carcinoma. A phase II study.
    Nordstrom, B.
    Salmi, T.
    Mirza, M.
    Abeler, V.
    Kristensen, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 266S - 266S
  • [10] Celecoxib plus cartioplatin in heavily pre-treated patients with recurrent ovarian carcinoma: Preliminary results of a Phase II study.
    Ferrandina, GM
    Legge, F
    Gallotta, V
    Lorusso, D
    Testa, AC
    Salutari, V
    Paglia, A
    Colangelo, M
    Fulfaro, F
    Scambia, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 469S - 469S
12345